Table 1 Demographic and clinical characteristics of patients in the overall study cohort and in the subgroup with follow-up CD4 tests 4 to 9 months after ART initiation.
| Â | Total (n = 488) | With CD4 test (n = 409) |
|---|---|---|
Female | 62.5% | 63.1% |
Age | Â | Â |
   30 & under | 29.3% | 29.6% |
   31-40 | 43.4 | 42.8 |
   41 & over | 27.3 | 27.6 |
Education | Â | Â |
   None | 15.5% | 16.8% |
   Primary | 46.7 | 47.3 |
   Secondary or greater | 37.8 | 36.0 |
Married currently | 44.1% | 44.9% |
Living | Â | Â |
   Alone | 6.0% | 6.1% |
   With child only | 24.5 | 23.8 |
   With adult +/- child | 69.6 | 70.1 |
Occupation | Â | Â |
   Employed | 28.3% | 28.5% |
   Self-employed | 32.2 | 32.0 |
   Unemployed | 39.4 | 39.5 |
Treated in government facility | 63.5% | 61.4% |
Treatment location | Â | Â |
   Clinic in capital | 49.8% | 50.4% |
   In other urban area | 26.4 | 25.4 |
   In rural area | 23.8 | 24.2 |
WHO stage at initiation | Â | Â |
   Stage 1 | 8.9% | 7.9% |
   Stage 2 | 25.4 | 26.5 |
   Stage 3 | 54.4 | 53.3 |
   Stage 4 | 11.3 | 12.3 |
Has treatment support partner | 88.7% | 89.7% |
Evidence of previous PMTCT (female only) | 6.2% | 4.7% |
Evidence of current or prior TB at initiation | 15.2% | 13.2% |
Baseline CD4 value | Â | Â |
   < = 100 | 37.4% | 36.7% |
   101-200 | 40.4 | 42.5 |
   201-350 | 20.9 | 19.3 |
   351 an above | 1.6 | 1.4 |
Weight in kg (SD) at initiation | Â | Â |
   Males | 57.2 (9.2) | 57.1 (9.2) |
   Females | 52.9 (9.7) | 52.9 (9.8) |